Monday 12 January 2026
Home      All news      Contact us      RSS     
zimbabweonlinenews - 1 month ago

Positive Phase 1b/2 Results from Ongoing REC-4881 TUPELO Trial Demonstrate Rapid and Durable Reductions in Polyp Burden in Familial Adenomatous Polyposis (FAP) at 25 Weeks

Positive Phase 1b/2 Results from Ongoing REC-4881 TUPELO Trial Demonstrate Rapid and Durable Reductions in Polyp Burden in Familial Adenomatous Polyposis (FAP) at 25 Weeks Leave a reply REC-4881 (4 mg QD) achieved rapid clinical activity, with 75% of evaluable patients showing reductions in total polyp burden and a 43% median reduction after 12 weeks ... Read more


Latest News
Hashtags:   

Positive

 | 

Phase

 | 

Results

 | 

Ongoing

 | 

TUPELO

 | 

Trial

 | 

Demonstrate

 | 

Rapid

 | 

Durable

 | 

Reductions

 | 

Polyp

 | 

Burden

 | 

Familial

 | 

Adenomatous

 | 

Polyposis

 | 

Weeks

 | 

Sources